Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Flanagan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Chronic Diseases in Canada|January 22, 2004
Lifetime costs of colon and rectal cancer management in CanadaJean Maroun, Edward Ng, Jean-Marie Berthelot, et al.
Population Health Metrics|September 5, 2015
The Population Health Model (POHEM): an overview of rationale, methods and applicationsDeirdre A Hennessy, William M Flanagan, Peter Tanuseputro, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
The OncoSim-Breast Cancer Microsimulation ModelJean H E Yong, Claude Nadeau, William M Flanagan, et al.
Arthritis and Rheumatism|June 26, 2008
Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996-1997 through 2003-2004Jacek A Kopec, M Mushfiqur Rahman, Eric C Sayre, et al.
CMAJ Open|September 23, 2020
Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation modelWilliam K Evans, Cindy L Gauvreau, William M Flanagan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 22, 2009
Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factorsDouglas S Lee, Maria Chiu, Douglas G Manuel, et al.
BMC Public Health|November 20, 2010
Validation of population-based disease simulation models: a review of concepts and methodsJacek A Kopec, Philippe Finès, Douglas G Manuel, et al.
International Journal of Technology Assessment in Health Care|March 22, 2013
Canadian Cancer Risk Management Model: evaluation of cancer controlWilliam K Evans, Michael C Wolfson, William M Flanagan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase I Study of DLYE5953A, an Anti-LY6E Antibody Covalently Linked to Monomethyl Auristatin E, in Patients with Refractory Solid TumorsSara M Tolaney, Khanh T Do, Joseph P Eder, et al.
Science (New York, N.Y.)|November 15, 2005
Small-molecule inhibition of TNF-alphaMolly M He, Annemarie Stroustrup Smith, Johan D Oslob, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chronic Diseases in Canada|January 22, 2004
Lifetime costs of colon and rectal cancer management in CanadaJean Maroun, Edward Ng, Jean-Marie Berthelot, et al.
Population Health Metrics|September 5, 2015
The Population Health Model (POHEM): an overview of rationale, methods and applicationsDeirdre A Hennessy, William M Flanagan, Peter Tanuseputro, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
The OncoSim-Breast Cancer Microsimulation ModelJean H E Yong, Claude Nadeau, William M Flanagan, et al.
Arthritis and Rheumatism|June 26, 2008
Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996-1997 through 2003-2004Jacek A Kopec, M Mushfiqur Rahman, Eric C Sayre, et al.
CMAJ Open|September 23, 2020
Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation modelWilliam K Evans, Cindy L Gauvreau, William M Flanagan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 22, 2009
Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factorsDouglas S Lee, Maria Chiu, Douglas G Manuel, et al.
BMC Public Health|November 20, 2010
Validation of population-based disease simulation models: a review of concepts and methodsJacek A Kopec, Philippe Finès, Douglas G Manuel, et al.
International Journal of Technology Assessment in Health Care|March 22, 2013
Canadian Cancer Risk Management Model: evaluation of cancer controlWilliam K Evans, Michael C Wolfson, William M Flanagan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase I Study of DLYE5953A, an Anti-LY6E Antibody Covalently Linked to Monomethyl Auristatin E, in Patients with Refractory Solid TumorsSara M Tolaney, Khanh T Do, Joseph P Eder, et al.
Science (New York, N.Y.)|November 15, 2005
Small-molecule inhibition of TNF-alphaMolly M He, Annemarie Stroustrup Smith, Johan D Oslob, et al.
Pageof 3